UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSL
4201
Brightstar Lottery PLC
BRSL
$2.03B
| $3.4M | ﹤0.01% |
192,707
+138,956
| +259% | +$2.73M |
|
4202
IPG Photonics
IPGP
$3.84B
| $3.4M | ﹤0.01% |
46,756
-32,647
| -41% | -$2.51M |
|
4203
Tarsus Pharmaceuticals
TARS
$2.84B
| $3.39M | ﹤0.01% |
61,307
-8,009
| -12% | -$364K |
|
4204
FlexShares International Quality Dividend Dynamic Index Fund
IQDY
$113M
| $3.39M | ﹤0.01% |
122,775
-1,331
| -1% | -$39.3K |
|
4205
PUT
Affirm
AFRM
$25.2B
| $3.39M | ﹤0.01% |
55,700
+30,700
| +123% | +$1.71M |
|
4206
CALL
Telus
TU
$15.3B
| $3.39M | ﹤0.01% |
250,000
| – | – |
|
4207
CareDx
CDNA
$2.42B
| $3.39M | ﹤0.01% |
158,314
+30,535
| +24% | +$743K |
|
4208
Invesco Pharmaceuticals ETF
PJP
$479M
| $3.38M | ﹤0.01% |
40,922
+5,587
| +16% | +$481K |
|
|
SII
4209
Sprott
SII
$3.03B
| $3.38M | ﹤0.01% |
80,151
+31,066
| +63% | +$1.37M |
|
4210
Liquidia Corp
LQDA
$8.02B
| $3.38M | ﹤0.01% |
287,327
+224,670
| +359% | +$2.46M |
|
|
SERV
4211
Serve Robotics
SERV
$432M
| $3.37M | ﹤0.01% |
+249,992
| New | +$2.63M |
|
4212
Arqit Quantum
ARQQ
$399M
| $3.37M | ﹤0.01% |
86,732
+84,627
| +4,020% | +$1.26M |
|
4213
Ducommun
DCO
$2.98B
| $3.37M | ﹤0.01% |
52,912
+29,218
| +123% | +$1.88M |
|
4214
Integra LifeSciences
IART
$1.34B
| $3.37M | ﹤0.01% |
148,468
+69,064
| +87% | +$1.51M |
|
4215
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.02B
| $3.36M | ﹤0.01% |
67,943
+364
| +0.5% | +$18.5K |
|
|
ZK
4216
DELISTED
Zeekr
ZK
| $3.35M | ﹤0.01% |
118,041
+117,112
| +12,606% | +$2.98M |
|
4217
First Trust Long/Short Equity ETF
FTLS
$2.5B
| $3.34M | ﹤0.01% |
50,730
+15,255
| +43% | +$997K |
|
4218
US Treasury 12 Month Bill ETF
OBIL
$307M
| $3.34M | ﹤0.01% |
66,637
+32,266
| +94% | +$1.62M |
|
4219
Mitek Systems
MITK
$834M
| $3.34M | ﹤0.01% |
299,673
+150,464
| +101% | +$1.4M |
|
|
BFS
4220
Saul Centers
BFS
$841M
| $3.33M | ﹤0.01% |
85,930
+42,063
| +96% | +$1.69M |
|
4221
Morgan Stanley Direct Lending Fund
MSDL
$1.3B
| $3.33M | ﹤0.01% |
161,272
+95,910
| +147% | +$1.96M |
|
|
MESO
4222
Mesoblast
MESO
$2.07B
| $3.33M | ﹤0.01% |
+168,253
| New | +$1.86M |
|
4223
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
| $3.32M | ﹤0.01% |
113,297
+10,561
| +10% | +$325K |
|
4224
Tilray
TLRY
$622M
| $3.31M | ﹤0.01% |
248,734
+213,381
| +604% | +$3.13M |
|
4225
PUT
Antero Resources
AR
$10.7B
| $3.3M | ﹤0.01% |
94,200
-19,400
| -17% | -$587K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.